Bristol-Myers Squibb Co BMY:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/27/23 EST
72.45UNCH (UNCH)
Volume
241,389
Close
72.45quote price arrow down-0.54 (-0.74%)
Volume
5,184,779
52 week range
62.35 - 81.43
Loading...
  • Open72.99
  • Day High73.45
  • Day Low72.34
  • Prev Close72.99
  • 52 Week High81.43
  • 52 Week High Date12/01/22
  • 52 Week Low62.35
  • 52 Week Low Date01/27/22

Key Stats

  • Market Cap154.04B
  • Shares Out2.13B
  • 10 Day Average Volume8.10M
  • Dividend2.28
  • Dividend Yield3.15%
  • Beta0.42
  • YTD % Change0.69

KEY STATS

  • Open72.99
  • Day High73.45
  • Day Low72.34
  • Prev Close72.99
  • 52 Week High81.43
  • 52 Week High Date12/01/22
  • 52 Week Low62.35
  • 52 Week Low Date01/27/22
  • Market Cap154.04B
  • Shares Out2.13B
  • 10 Day Average Volume8.10M
  • Dividend2.28
  • Dividend Yield3.15%
  • Beta0.42
  • YTD % Change0.69

RATIOS/PROFITABILITY

  • EPS (TTM)3.07
  • P/E (TTM)23.61
  • Fwd P/E (NTM)9.40
  • EBITDA (TTM)22.244B
  • ROE (TTM)19.11%
  • Revenue (TTM)46.738B
  • Gross Margin (TTM)78.91%
  • Net Margin (TTM)14.32%
  • Debt To Equity (MRQ)119.67%

EVENTS

  • Earnings Date02/02/2023(est)
  • Ex Div Date01/05/2023
  • Div Amount0.57
  • Split Date-
  • Split Factor-

Related Video

Pro Picks: Watch all of Thursday's big stock calls on CNBC
VIDEO8:1408:14
Pro Picks: Watch all of Thursday's big stock calls on CNBC

Profile

MORE
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically synthesized or small molecule drugs and products produced from biological processes, called biologics....
Giovanni Caforio M.D.
Chairman of the Board, Chief Executive Officer
David Elkins
Executive Vice President, Chief Financial Officer, Member of the Leadership Team
Elizabeth Mily
Executive Vice President - Strategy and Business Development, Member of the Leadership Team
Sandra Leung
Executive Vice President, General Counsel, Member of the Leadership Team
Christopher Boerner Ph.D.
Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team
Address
430 E. 29Th Street, 14 Floor
New York, NY
10016
United States

Top Peers